Broad Institute
APRIL 22, 2024
Jennifer Listgarten By Rose Circeo April 22, 2024 Jennifer Listgarten Jennifer Listgarten is a Professor in the Department of Electrical Engineering and Computer Science, the Center for Computational Biology, and the Bioengineering program at the University of California, Berkeley. She completed her Ph.D. Previous Jenn Nava Next Jesse Boehm
Drug Target Review
NOVEMBER 27, 2023
a biopharmaceutical company, from August 2007 until its acquisition by Roche Holding AG in 2011. Dr Worland was an NIH postdoctoral fellow in molecular biology at Harvard University and completed a Ph.D. Previously, Dr Worland served as Chief Executive Officer of Anadys Pharmaceuticals, Inc., He received his B.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
JUNE 19, 2024
Mr Culley served from 2007 to 2010 as Mast’s Chief Business Officer and Senior Vice President, from 2006 to 2007 as Mast’s Senior Vice President, Business Development, and from 2004 to 2006 as Mast’s Vice President, Business Development. SVRA) in April 2017. from The Johnson School of Business at Cornell University.
Broad Institute
APRIL 25, 2024
The project is a collaboration between the Broad and the African Center of Excellence for Genomics of Infectious Diseases (ACEGID) at Redeemer’s University outside Lagos in Nigeria, where Happi is a professor of molecular biology and genomics.
BMG Labtech
JANUARY 23, 2024
4 The crystal structure of the luciferase from Renilla reniformis was determined in 2007. 5 The usefulness of bioluminescence as a tool to study biology at the molecular level jump started a search for alternative luciferases, in many cases from other marine organisms that were bioluminescent.
Dark Matter Blog
JULY 16, 2021
The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. I had a first-hand role in raising money from Wall Street by being part of an IPO roadshow as Synta went public in 2007.
Codon
MARCH 12, 2023
I recently asked for recommendations of “classic” papers in molecular biology. Not all take insulin, but Medicare spending on this single compound increased 840% between 2007 and 2017, from $1.4 Twitter feels a bit like an empty void these days, but it still drums up useful things every now and again. had diabetes.
Expert insights. Personalized for you.
52 
Let's personalize your content